Could a small molecule complement regenerative therapies in spinal cord injury?
Researchers from Boston Children’s Hospital have identified a small molecule drug with the potential to restore the ability to walk in patients with spinal cord injury.
A recent study, published in Cell, suggests a systemically given small molecule could revive neural circuits in mice with spinal cord injury, restoring their ability to walk. The research, which was carried out at Boston Children’s Hospital (MA, USA), could complement regenerative therapies, aiding those with paralysis caused by spinal cord injury.